Follow-The-Filings

Security · featured owners

CRBU Caribou Biosciences Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $1M

CRBU (Caribou Biosciences Inc.) is held in 1 featured 13F book as of 2026 Q2. Lee Ainslie - Maverick Capital is the largest tracked holder by portfolio weight (0.01%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (Lee Ainslie - Maverick Capital) · not free-float ownership

  1. Lee Ainslie 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Lee Ainslie - Maverick Capital 2026 Q2 0.01% Hold 652,542 $1M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,2.05,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Feb 25, 2026 Filing Doc
4 Period Feb 20, 2026 · 4 forms Filing Doc
4 Period Feb 20, 2026 · 9 forms Filing Doc
4 Period Mar 14, 2025 Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $34.48M $9.99M $11.16M
Net income -$102.07M -$149.1M -$148.12M
Net margin * -296.1% -1491.9% -1327.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $338.84M $219.38M $145.23M
Total non-current assets * $93.37M $93.94M $30.14M
Total assets $432.21M $313.31M $175.37M
Total current liabilities $28.3M $30.65M $25.41M
Total non-current liabilities * $35.51M $29.71M $27.78M
Total equity $368.4M $252.95M $122.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$93.29M -$138.2M -$110.99M
Cash from investing -$68.18M $86.61M $102.24M
Cash from financing $154.3M $16.72M $4.82M
Net change in cash -$7.18M -$34.87M -$3.93M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders